Carrier Screening Market: Size, Trends & Forecast | 2034

1. Carrier Screening Market: Size, Trends & Forecast | 2034 What is the Carrier Screening Market and What is Driving Its Growth? The global carrier screening market was valued at USD 2.00 Billion in 2024 and is projected to grow at a CAGR of 12.40% during the forecast period of 2025-2034. The market is expected to reach a value of approximately USD 6.44 Billion by 2034. This substantial growth is propelled by increasing awareness regarding genetic disorders, advancements in genomic technologies, and rising demand for preconception and prenatal screening. Carrier screening plays a crucial role in identifying individuals who carry gene mutations that could be passed on to their offspring, thereby preventing inherited diseases and reducing the prevalence of severe genetic conditions. Improved accessibility to genetic testing services through fertility clinics, hospitals, and diagnostic laboratories further supports market expansion. Additionally, the shift towards expanded carrier screening and customized panels has enhanced the scope and precision of genetic testing, fueling adoption worldwide. Carrier Screening Market Segmentation by Type and Product & Service Breakup by Type: ● Expanded Carrier Screening: These comprehensive panels assess multiple genetic disorders simultaneously, offering broader risk identification across diverse populations. ● Targeted Disease Carrier Screening: Focuses on screening specific, population-relevant genetic disorders, often driven by ethnicity or family history. ● Customized Panel Testing: Tailored tests designed for unique patient or clinician needs, balancing specificity and breadth. ● Predesigned Panel Testing: Standardized panels designed for common hereditary disorders based on guidelines and clinical best practices. Breakup by Product and Service: ● Product Segment: Encompasses test kits, reagents, and consumables required for carrier screening assays.

2. ● Service Segment: Includes laboratory testing, genetic counseling, reporting, and related clinical services. The service segment is growing significantly due to the complex nature of genetic test interpretation and increasing demand for professional genetic counseling. Market Segmentation by Technology and Medical Condition Breakup by Technology: ● DNA Sequencing: Next-generation sequencing technologies dominate due to depth, accuracy, and ability to analyze numerous genes simultaneously. ● Polymerase Chain Reaction (PCR): A well-established method that detects specific gene mutations rapidly and cost-effectively. ● Microarrays: Used for detecting known mutations and genetic variants at moderate scale. ● Others: Include methods like multiplex ligation-dependent probe amplification (MLPA) and hybridization assays. Breakup by Medical Condition: ● Hematologic Conditions: Including sickle cell anemia, beta-thalassemia, and other blood disorders. ● Pulmonary Conditions: Most notably, cystic fibrosis. ● Neurological Conditions: Such as spinal muscular atrophy and Tay-Sachs disease. ● Others: Cover a range of rare genetic disorders including metabolic and endocrine abnormalities. End Users and Regional Dynamics of the Carrier Screening Market Breakup by End User: ● Hospitals and Clinics: Major users offering prenatal, preconception, and newborn screening programs. ● Laboratories: Crucial role in genetic test execution, interpretation, and reporting. ● Fertility Clinics: Driving growth by incorporating carrier screening in assisted reproductive technologies (ART). ● Others: Includes research centers and direct-to-consumer testing providers.

3. Regional Insights: ● North America: Holds dominant market share due to advanced healthcare systems, favorable reimbursement policies, and high genetic disorder awareness. ● Europe: Significant growth supported by government screening initiatives and increasing clinical adoption. ● Asia Pacific: Fastest-growing region due to rising healthcare infrastructure, increasing fertility treatments, and expanding genetic testing awareness. ● Latin America and Middle East & Africa: Emerging markets marked by growing investment in healthcare and genetic services. Leading Companies in the Carrier Screening Market ● Thermo Fisher Scientific ● Invitae Corporation ● Fulgent Genetics ● Otogenetics ● OPKO Health Inc. ● Quest Diagnostics Clinical Laboratories, Inc. ● Myriad Genetics, Inc. ● Natera, Inc. ● Laboratory Corporation of America® Holdings ● Illumina, Inc ● MedGenome ● CENTOGENE N.V. Key players focus on innovation in genetic testing platforms, expansion of test panels, improved counseling services, and strategic partnerships to strengthen market presence. Importance of Carrier Screening in Healthcare ● Facilitates early identification of carrier status for inherited genetic disorders. ● Enables couples to make informed reproductive decisions, reducing birth defects and genetic diseases. ● Improves healthcare outcomes through personalized genetic counseling. ● Enhances public health by decreasing the incidence of hereditary diseases over generations. ● Supports fertility clinics and prenatal care with precise genetic risk assessments. Bullet Points: Key Growth Drivers for the Carrier Screening Market

4. ● Rising awareness about genetic diseases and prenatal health. ● Technological advances enabling expanded and customized carrier screening. ● Increasing adoption of assisted reproductive technologies (ART). ● Growing accessibility and affordability of genetic testing services. ● Favorable reimbursement scenarios in developed markets. ● Government initiatives promoting carrier screening and newborn screening programs. ● Expansion of direct-to-consumer genetic testing platforms. Challenges and Opportunities Challenges: ● Privacy and ethical concerns regarding genetic information. ● Cost barriers and insurance coverage variability in some regions. ● Requirement for skilled genetic counselors to interpret complex results. Opportunities: ● Integration of AI and machine learning to enhance test interpretation. ● Expansion into emerging markets driven by increasing healthcare investments. ● Development of comprehensive screening including rare diseases. ● Collaboration with fertility clinics to standardize carrier screening protocols. Find More Reports Dental Equipment Market India Vitamin Gummies Market India Medical Gases Market Osteoarthritis Therapeutics Market About Us: Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower

5. clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector. Media Contact: Company Name: Claight Corporation Contact Person: Roshan Kumar, Digital Marketing Email: sales@expertmarketresearch.com Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790 Address: 30 North Gould Street, Sheridan, WY 82801, USA Website: www.expertmarketresearch.com